Medicine & Life Sciences
venetoclax
100%
Acute Myeloid Leukemia
79%
Regulatory B-Lymphocytes
50%
T-Lymphocytes
50%
Fetal Blood
46%
Chimeric Antigen Receptors
44%
Graft vs Host Disease
36%
CD19 Antigens
34%
Myelodysplastic Syndromes
31%
Interleukin-10
27%
Stem Cells
27%
Interleukin-15
27%
Natural Killer Cells
25%
B-Cell Chronic Lymphocytic Leukemia
25%
Tumor Microenvironment
24%
Cell- and Tissue-Based Therapy
21%
pevonedistat
19%
Tissue Donors
18%
Immunosuppressive Agents
18%
Transplantation
17%
Adoptive Immunotherapy
17%
Palladium
16%
Lenalidomide
16%
PCI 32765
16%
SARS Virus
16%
Leukemia, Myelomonocytic, Chronic
15%
Neoplasms
15%
KIR Receptors
15%
BK Virus
15%
GATA2 Deficiency
15%
Progressive Multifocal Leukoencephalopathy
14%
Relaxation Therapy
14%
Azacitidine
14%
Bacillus cereus
14%
Stem Cell Transplantation
14%
Catheter-Related Infections
13%
Lymphoma, Large B-Cell, Diffuse
13%
STAT3 Transcription Factor
13%
Polyneuropathies
12%
Cytarabine
12%
Blood Cells
12%
Long Noncoding RNA
11%
Amyotrophic Lateral Sclerosis
11%
B-Lymphocytes
11%
B-Cell Lymphoma
11%
Drive
11%
Hematopoietic Stem Cells
11%
6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-9H-purine-9-propanamine
10%
Regulatory T-Lymphocytes
10%
Multiple Myeloma
10%